Ares Capital Corp (ARCC) · Oct 27, 2026 · Earnings
Miss — Core EPS $0.46 vs ~$0.48 consensus
Ares Capital earnings came in below consensus as slower deal activity pressured core EPS, though the dividend, liquidity and credit profile remained intact.
Ares Capital is a large U.S. middle-market direct lender, building scale through senior-secured credit, sponsor relationships and the planned acquisition of MidCap Financial Investment Corporation. Its near-term earnings story depends on keeping portfolio yields high while converting a slower deal environment into new originations.
The quarter missed the earnings bar. Core EPS was $0.46, below the published consensus of roughly $0.48, while GAAP EPS fell to $0.44 from $0.57 a year ago. The miss is modest, but it means the quarter did not validate management’s “solid results” framing. The company’s reported core EPS was $0.46.
| Metric | Q3 2026 | Comparison | Filing location |
|---|---|---|---|
| Core EPS | $0.46 | $0.50 Q3 2025; ~$0.48 consensus | Core EPS reconciliation |
| GAAP EPS | $0.44 | $0.57 Q3 2025 | Financial statements |
| Net investment income | $328M / $0.46 per share | $338M / $0.48 | Financial highlights |
| Dividend declared | $0.48 per share | $0.48 prior quarter and year-ago quarter | Dividend announcement |
| Portfolio investments at fair value | $29.2B | $29.5B at Dec. 31, 2025 | Balance sheet |
| NAV per share | $19.31 | $19.94 at Dec. 31, 2025 | Balance sheet |
| Debt/equity | 1.11x | 1.12x at Dec. 31, 2025 | Portfolio information |
| Q3 gross commitments | $2.1B | $3.9B Q3 2025 | Portfolio activity |
| Q3 exits | $2.5B | $2.6B Q3 2025 | Portfolio activity |
| Non-accruals at fair value | 1.4% | 1.2% at Dec. 31, 2025 | Portfolio information |
Underlying income softened and did not fully cover the dividend. Net investment income declined to $328 million, or $0.46 per share, from $338 million, or $0.48 per share, a year earlier. Against the declared $0.48 dividend, that is a small quarterly coverage shortfall on the company’s core earnings measure. The company declared a fourth-quarter dividend of $0.48 per share.
The pressure came more from activity than from an obvious credit break. Gross commitments dropped to $2.1 billion from $3.9 billion a year earlier, and exits exceeded new commitments during the quarter. Management said the transaction environment was slower, but reported a $2.5 billion backlog as of October 22 and stronger activity entering the fourth quarter. That backlog is meaningful, but it is not yet funded revenue: the filing says closing remains subject to documentation and other conditions. The company made new investment commitments of approximately $2.1 billion in the third quarter of 2026.
Credit quality remains a support, not a complete offset. The portfolio’s average investment grade stayed at 3.1, while non-accruals rose to 2.4% of investments at amortized cost, or 1.4% at fair value, from 1.8% and 1.2% respectively at year-end. That deterioration is still limited in absolute terms, but it makes the lower NAV and the earnings miss more consequential than if credit metrics had been flat. Loans on non-accrual status represented 2.4% of total investments at amortized cost as of September 30, 2026. 〔0〕
Funding flexibility improved even as growth slowed. Ares added $750 million of seven-year unsecured notes, refinanced a CLO at a lower blended spread and extended that financing’s maturity to 2038. It ended the quarter with approximately $6.9 billion of available borrowing capacity and roughly $7 billion of liquidity, while net leverage declined modestly. The capital position therefore gives the company room to fund the backlog and the MidCap transaction, but the quarter itself showed less deployment momentum than the market expected. Ares Capital increased its debt capacity through a $750 million issuance of seven-year unsecured notes.
Bottom line: This was a modest earnings miss, driven by slower origination activity and slightly weaker credit metrics rather than a funding problem. The backlog, liquidity and stable dividend keep the business story intact, but the quarter did not improve the near-term earnings trajectory relative to expectations.
MFIC transaction approval and closing process
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!